The molecular mechanism behind SNP rs992531 and poor breast cancer outcome in ER-positive cases may therefore involve altered RHOBTB2 expression and its interplay with cyclin D1 and the oestrogen receptor (Figure 1A). This evidence concerns the gene RHOBTB2 and breast cancer.